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medium, provided the original work is properly cited.We used a novel approach of cytostatically induced leucocyte depletion and
subsequent reconstitution with leucocytes deprived of classical (inflammatory/
Gr1hi) or non-classical (resident/Gr1lo) monocytes to dissect their differential role
in atheroprogression under high-fat diet (HFD). Apolipoprotein E-deficient
(Apoe/) mice lacking classical but not non-classical monocytes displayed
reduced lesion size and macrophage and apoptotic cell content. Conversely,
HFD induced a selective expansion of classical monocytes in blood and bone
marrow. Increased CXCL1 levels accompanied by higher expression of its receptor
CXCR2 on classical monocytes and inhibition of monocytosis by CXCL1-neutral-
ization indicated a preferential role for the CXCL1/CXCR2 axis in mobilizing
classical monocytes during hypercholesterolemia. Studies correlating circulating
and lesional classical monocytes in gene-deficient Apoe/ mice, adoptive trans-
fer of gene-deficient cells and pharmacological modulation during intravital
microscopy of the carotid artery revealed a crucial function of CCR1 and CCR5
but not CCR2 or CX3CR1 in classical monocyte recruitment to atherosclerotic
vessels. Collectively, these data establish the impact of classical monocytes on
atheroprogression, identify a sequential role of CXCL1 in their mobilization and
CCR1/CCR5 in their recruitment.INTRODUCTION
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472significance of monocytes in atheroprogression (Ylitalo et al,
1994), with more recent work indicating a stage-specific
influence, whereby monocytes promote atherosclerosis at early
stages but not at later time points (Stoneman et al, 2007). With
the emergence of at least two functionally different monocyte
subsets in humans and mice termed classical (inflammatory,
Gr1hi) and non-classical (resident, Gr1lo) monocytes (Geissmann
et al, 2003), it remains to be determined, which differential
impact they have on atherosclerosis.
Hypercholesterolemia selectively increases circulating
classical monocyte counts (Swirski et al, 2007) and induces
phenotypic changes favoring emigration into atherosclerotic
lesions (Soehnlein et al, 2009), suggesting a prominent role of
classical monocytes in atherosclerosis. Fundamental to the
importance of monocytes in atherosclerosis is their accumula-
tion within atherosclerotic lesions (Weber et al, 2008) a process
regulated at various levels, i.e. mobilization from sites of
production, recruitment, and survival in the lesion (Gautier
et al, 2009). Extravasation of monocytes requires the co-
ordinated interaction of selectins, adhesion molecules, and
chemokines (Imhof & Aurrand-Lions, 2004). With the discovery
of monocyte subsets a concept has emerged, wherein the
relative expression of adhesion molecules or chemokine
receptors governs their recruitment behaviour. In this context,
it has been suggested that classical monocytes, which express
higher levels of CCR2 compared to non-classical monocytes
(Weber et al, 2000), are recruited to the site of inflammation
in Ccr2/ mice in lower numbers (Boring et al, 1998). In
addition, chemokines and their receptors fulfill important
roles in monocyte mobilization from the bone marrow (BM).
Accordingly, as CCR2 is essential in mobilization of classical
monocytes from the BM, these mice also exhibit markedly
reduced numbers of circulating monocytes (Serbina & Pamer,
2006). Beyond recruitment and mobilization, chemokine
receptor axes can crucially affect monocyte life span. For
instance, absence of CX3CR1 results in reduction of non-classical
monocytes blood counts, which are restored by introduction of
a Bcl2 transgene, suggesting that the CX3C axis provides a
survival signal (Landsman et al, 2009).
Thus, the objective of this study was to dissect a differential
role of monocyte subsets in early stages of atherosclerosis, to
clarify the chemokine-driven mechanisms underlying hyper-
cholesterolemia-induced monocytosis, and to examine the
functional involvement of chemokine receptor axes in the
recruitment pattern of these monocytes independently of their
homeostatic influence.RESULTS
Classical monocytes drive atheroprogression
As selective depletion of monocyte subsets is not feasible we
developed a novel approach to dissect the specific contribution
of monocyte subsets to atherosclerosis (Fig 1A). In Apoe/,
mice fed a high-fat diet (HFD) for 4 weeks, the mobilization of
leucocytes from the BM was abrogated by application of the
cytostatic drug cyclophosphamide (CPM) during subsequent 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.4 weeks of HFD. This resulted in an absolute leucopenia
(Supporting Information Table 1). To address a specific role of
monocyte subsets, mice were repeatedly reconstituted with
white blood cells from age-matched donor mice, in which either
classical or non-classical monocytes were selectively removed
by fluorescence activated cell sorting (FACS). Lipid levels,
body and spleen weight were not influenced by this regimen
(Supporting Information Table 2 and 3). In addition, antibody-
based depletion of monocyte subsets did not alter white blood
cell activation, as assessed by analysis of CD11b expression,
CD62L shedding, Annexin V-binding, and reactive oxygen
species production (Supporting Information Fig 1). To further
validate the transfer efficacy of the reconstitution protocol,
we employed the CD45.1/CD45.2 system. The results demon-
strate that this protocol allowed for virtual reconstitution of
white blood cell subsets (Supporting Information Fig 2) and
enabled prominent lesional accumulation of donor leucocytes
(Supporting Information Fig 3).
After 8 weeks of HFD,Apoe/mice displayed atherosclerotic
lesion formation in the aortic root and the thoracic aorta
which was significantly diminished by application of CPM for
4 weeks (Fig 1B–D). While reconstitution of leucopenic mice
with whole white blood cells from donor mice restored lesion
sizes, removal of classical monocytes from donor leucocytes
but not non-classical monocytes reduced atherosclerotic
lesion area to levels observed in mice receiving CPM only
(Fig 1B–D). Immunohistochemical analysis of Mac2þ macro-
phage content in atherosclerotic lesions of the aortic root
followed a similar pattern (Fig 1E). When analysing the
number of apoptotic TUNELþ cells in aortic roots, half of
which originated from macrophages (Supporting Information
Fig 4), we found a significant increase in mice reconstituted
with leucocytes depleted of classical monocytes (Fig 1F),
which are known to display higher phagocytic capacity and
thereby contribute to the clearance of apoptotic cells. Analysis
of collagen content by sirius red staining revealed a reduction
in aortic collagen content in CPM-treated groups, likely due
to decreased collagen synthesis in response to CPM (Hansen
& Lorenzen, 1977). In addition, no differences within the
CPM-treated groups were identified (Fig 1G). Taken together,
these data reveal a dominant role of classical monocytes in
atheroprogression.
mCXCL1 mediates hypercholesterolemia-induced
monocytosis
Hypercholesterolemia has been reported to affect counts,
phenotype, and function of peripheral blood leucocyte subsets.
Increased monocyte counts in mice receiving HFD have been
attributed to a selective expansion of the classical monocyte
subset (Swirski et al, 2007). In our hands, Apoe/ mice fed a
HFD exhibited a leucocytosis comprised of increased counts of
neutrophils and classical monocytes (Fig 2A and B).
We next aimed at elucidating mechanisms underlying HFD-
induced monocytosis. Prolonged life span, reduced conversion,
and enhanced production have been implicated in causing HFD-
mediated classical monocytosis (Murphy et al, 2011; Swirski
et al, 2007). Hence, we examined facilitated mobilization asEMBO Mol Med (2013) 5, 471–481
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Figure 1. Classical monocytes are decisive during atheroprogression.
A. Scheme illustrating the approach to investigate the individual contribution of monocyte subsets to atherosclerotic lesion formation. Male Apoe/mice 6
weeks of agewere fed a HFD for a total of 8 weeks. After 4weeks of HFD, groups I to IV were treated with i.p. CPM 2/week. Groups II to IV were reconstituted
with leucocytes from Apoe/ donor mice by i.v. injections 2/week using one donor mouse/recipient each 1 day after CPM treatment. Group II was
substituted with all CD45þleucocytes, group III received CD45þ leucocytes without classical monocytes, and group IV was reconstituted with CD45þ
leucocytes without non-classical monocytes, in each case depleted by sorting for classical versus non-classical monocytes.
B–D. Assessment of atherosclerotic lesion size after staining aortic root sections (B,C) or aortas (D) with oil-red-O. Representative images and quantification are
displayed.
E. Quantification of monocyte/macrophage content in aortic roots following Mac2 staining.
F. Quantification of TUNELþ apoptotic cells.
G. Analysis of collagen content by sirius red staining and analysis under polarized light. All data are expressed as mean SD. Denotes significant differences
between groups. n¼ 912 for each group (One-way ANOVA with Newman–Keuls post hoc test).complementary mechanisms of classical monocytosis. The
CCR2 ligands CCL2/MCP-1 and CCL7/MCP-3 are crucially
involved in the mobilization of classical monocytes from the BM
under steady-state and inflammatory conditions (Tsou et al,
2007). However, neither CCL2 nor CCL7 serum levels were
found to be increased under HFD (Supporting Information
Fig 5). Accordingly, Ccr2/Apoe/ mice displayed reducedEMBO Mol Med (2013) 5, 471–481 circulating classical monocyte counts at steady-state but a
significant increase after HFD for 8 weeks by a relative degree
similar to that observed in Ccr2þ/þApoe/ mice (Supporting
Information Fig 6), suggesting a mechanism independent of
the CCR2 axis to be responsible for HFD-induced mono-
cytosis. Likewise, comparable increases in classical monocyte
counts were found in Ccr1/Apoe/, Ccr5/Apoe/, and2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 473
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Figure 2. CXCL1 mediates hypercholesterolemia-induced expansion of classical monocytes.
A. Apoe/mice were fed normal chow or HFD for 8 weeks. Monocyte subsets were identified using antibodies to CD45, CD11b, CD115, and Gr1.
B. Quantification of total monocyte counts, absolute counts of classical and non-classical monocytes, and neutrophils in the blood of Apoe/mice fed normal
chow or HFD for 8 weeks.
C. Histograms depict specific fluorescence intensities of circulating monocyte subsets after staining with an antibody to CXCR2 or isotype control.
D. Isotype-corrected cell surface expression of CXCR2 on mouse monocyte subsets in Apoe/mice fed normal chow. Denotes significant increase in classical
monocytes in mice on HFD.
E. Serum mCXCL1 levels in Apoe/ mice fed normal chow or HFD for 8 weeks. Denotes significant differences.
F. Analysis of classical monocyte counts in blood, BM, and spleen 1 h after injection of PBS or recombinant murine CXCL1 (40mg/kg). Denotes significant
differences.
G–I. Apoe/mice were fed a HFD for 4 weeks and injected (5mg i.p., daily during first week, 3/week in subsequent weeks) with isotype control or an antibody to
mCXCL1. All data are expressed as mean SD. Denotes significant difference between indicated groups. n¼ 8 for each group (Students t-test). (G) Absolute
number of circulating classical monocytes in Apoe/ mice before and after 1 and 4 weeks of feeding HFD. (H) Lesion size in the aortic root. (I) Absolute
numbers of classical monocytes (left) and macrophages (right) in the aorta, as assessed by flow cytometry.
474Cx3cr1
/Apoe/mice (Supporting Information Fig 6), indicat-
ing a dispensable role of these receptors in HFD-induced
classical monocytosis.
Since neutrophil homeostasis in steady-state and during
hypercholesterolemia is regulated via the CXCR2-CXCL1 axis
(Drechsler et al, 2010; Martin et al, 2003), we investigated 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.whether this also applies to classical monocytes. We found
CXCR2 to be expressed on both monocyte subsets with higher
surface levels on classical monocytes (Fig 2C and D). Upon
HFD, CXCR2 expression was increased on circulating classical
monocytes but remained unaltered on non-classical monocytes
(Supporting Information Fig 7). In addition, serum levels ofEMBO Mol Med (2013) 5, 471–481
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Oliver Soehnlein et al.mCXCL1 were significantly elevated in Apoe/mice fed a
HFD (Fig 2E). Thus, both lines of evidence imply a potential
involvement of CXCL1-CXCR2 in the regulation of classical
monocytes homeostasis under HFD. The ability of CXCL1 to
mobilize classical monocytes was further tested by intravenous
injection of rmCXCL1 (Fig 2F). Whereas circulating non-
classical monocyte levels remained stable, blood classical
monocyte levels increased with concomitant decreases in
BM and spleen (Fig 2F), the latter being a recently identified
reservoir for monocytes (Swirski et al, 2009). To prove the
importance of CXCL1 in HFD-induced monocytosis, we treated
Apoe/ mice on HFD with an antibody to CXCL1 or isotype
control. Whereas classical monocyte counts significantly
increased in mice treated with isotype control, this was
prevented by treatment with the anti-CXCL1 antibody
(Fig 2G). In line, numbers of classical monocytes in spleen
and BM showed a tendency towards an increase in mice
receiving the anti-CXCL1 antibody (Supporting Information Fig
8). Aortic root sections of anti-CXCL1 treated mice displayed
smaller lesions (Fig 2H) characterized by lower numbers of
lesional classical monocytes and macrophages (Fig 2I). The
relevance of CXCL1 in patients was further assessed in plasma
of a previously described patient cohort with moderate
hypercholesterolemia (Garlichs et al, 2001). In these patients,
we found increased levels of CXCL1 as compared to controls
(Supporting Information Fig 9). Taken together, the increase
in CXCL1 levels in conjunction with a differential CXCR2
expression pattern indicates that this chemokine/receptor-
axis is crucially involved in mediating the HFD-induced
mobilization of classical monocytes.0 
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EMBO Mol Med (2013) 5, 471–481 Arterial recruitment of classical monocytes depends on CCR1
and CCR5
Previous studies have suggested pivotal contributions of CCR2
and CX3CR1 to monocyte and macrophage accumulation in
atherosclerotic lesions (Combadiere et al, 2008; Tacke et al,
2007). However, leucocyte accumulation at sites of inflamma-
tion is regulated at various levels, namely mobilization from
sites of production, recruitment, and life span. Since CCR2 is
crucial for monocytemobilization during inflammation (Serbina
& Pamer, 2006), while CX3CR1 confers survival signals in
monocytes and plaque macrophages (Landsman et al, 2009),
we aimed at discerning such mechanisms from recruitment.
Given the dominant role of classical monocytes in athero-
progression established herein, we evaluated the relevance
of CCR1, CCR2, CCR5, and CX3CR1 in the recruitment of this
subset to atherosclerotic arteries only. Notably, HFD did
not alter surface expression of chemokine receptors on
classical monocytes, although mRNA levels were up-regulated
(Supporting Information Fig 7). In addition, expression of
decoy receptors D6 and CXCR7 on the surface of classical
monocytes was not affected by HFD (Supporting Information
Fig 10). Similarly, expression of CD44, which can serve as
CCL5 co-receptor, did not change following HFD (Supporting
Information Fig 10). Next, we quantified classical monocyte
counts in aortic cell suspensions of Apoe/, Apoe/Ccr1/,
Apoe/Ccr2/, Apoe/Ccr5/, and Apoe/Cx3cr1
/ mice
by flow cytometry (Supporting Information Fig 11). Compared
to controlApoe/mice, the number of classical monocytes was
significantly reduced in aortas of atherosclerotic mice lacking
CCR1, CCR2, and CCR5 but not of those lacking CX3CR1* 
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476both after 4 weeks (Supporting Information Table 4) and
8 weeks (Fig 3A) of HFD. In line with a role in mobilization
(Serbina & Pamer, 2006; Tsou et al, 2007), Apoe/Ccr2/mice
displayed reduced classical monocyte counts in the circulation,
whereas no differences were observed in Apoe/Ccr1/,
Apoe/Ccr5/, and Apoe/Cx3cr1
/mice (Fig 3B and C). To
further discriminate between homeostasis and recruitment, we
correlated the counts of circulating and aortic classical
monocytes. While the two parameters were strongly correlated
in Apoe/, Apoe/Ccr2/, and Apoe/Cx3cr1
/ mice, no
correlation was observed in Apoe/Ccr1/ or Apoe/Ccr5/
mice (Fig 3D), suggesting a recruitment deficit in the latter two
strains.Whereasmacrophage accumulation wasmoremarkedly
reduced in Apoe/Cx3cr1
/ mice than in Apoe/Ccr2/
and Apoe/Ccr5/ mice at both time points, consistent with
a role of CX3CR1 monocytes and in macrophage survival
(Landsman et al, 2009), the absence of CCR1 limited macro-
phage accumulation at early time points but appeared to
favor macrophage accumulation at later stages (Supporting
Information Table 4).
To corroborate these findings, we performed adoptive
transfer experiments using classical monocytes sorted
from BM of Apoe/, Apoe/Ccr1/, Apoe/Ccr2/,
Apoe/Ccr5/, and Apoe/Cx3cr1
/mice. From each donor
strain, 106 classical monocytes were labelled with carboxy-
fluorescein succinimidyl ester (CFSE) as a cell tracker and
injected intravenously into Apoe/ mice that had been on
HFD for 8 weeks. After 24 h, adoptively transferred classical
monocytes were quantified in aortic homogenates of
recipient mice (Fig 4A and B and Supporting Information
Fig 12). The recruitment of classical monocytes deficient in
CCR1 or CCR5 but not of those deficient in CCR2 or CX3CR1
was severely diminished, when compared to monocytes with
intact chemokine receptor profile. To further substantiate these
findings, we employed the same strategy but instead used
the CD45.1/CD45.2 system to monitor aortic recruitment of
classical monocytes. Based on improved discrimination of
donor cells within the aortas of CD45.1/Ldlr/ recipient mice,
the results corroborate the importance of CCR1 and CCR5 for
arterial monocyte influx (Fig 4C and D).
This approach was further complemented by intravital
microscopy of the carotid artery using Apoe/Cx3cr1
egfp/þ
reporter mice. To specifically track classical monocytes, a
PE-conjugated antibody to Gr1 was injected, rendering
classical monocytes red/green fluorescent (Fig 4E). The
involvement of CCR1, CCR2, CCR5, or CX3CR1 in the
adhesion of classical monocytes to carotid arteries of
Apoe/Cx3cr1
egfp/þ mice after 8 weeks of HFD was investi-
gated by intraperitoneal administration of specific antagonists
to the respective chemokine receptor 1 h prior to recording.
Inhibition of CCR1 or CCR5 markedly reduced luminal
adhesion of classical monocytes, an effect not observed by
the presence of antagonists to CCR2 or CX3CR1 (Fig 4F).
Collectively, these data point at a prevalent function of CCR1
and CCR5 in the recruitment of classical monocytes under
acute as well as chronic inflammatory and atherogenic
conditions. 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.DISCUSSION
The importance of monocytes/macrophages in atherosclerosis
is widely acknowledged. However, the principal mechanisms of
their proatherogenic function, namely differential contributions
of monocyte subsets, the control of their homeostasis and
recruitment in hypercholesterolemia and atherosclerosis remain
insufficiently defined. Herein, we have unequivocally estab-
lished a predominant role of classical monocytes in atheropro-
gression. As a major risk factor for atherosclerosis, we found
HFD-induced hypercholesterolemia to enhance classical mono-
cytes counts by engaging the mCXCL1-CXCR2 axis. Finally and
contrary to previous reports, the CCL5 receptors CCR1 and CCR5
were identified to be essential for the recruitment of classical
monocytes to atherosclerotic arteries.
Our data provide several lines of evidence for differential
roles of the chemokine receptors CXCR2, CCR1, CCR2, CCR5,
and CX3CR1 in arterial monocyte accumulation. Previous
studies revealed diminished atherosclerotic plaque formation
in mice deficient in these receptors or their respective ligands
(Gautier et al, 2009). However, chemokine receptors do not only
control monocyte recruitment at sites of inflammation but
also their mobilization from the BM, and their life span (Gautier
et al, 2009). CXCR2 has been shown to mediate recruitment of
monocytes and neutrophils to atherosclerotic arteries (Boisvert
et al, 1998; Drechsler et al, 2010), in part explaining the reduced
atherosclerotic lesion formation in CXCR2-deficient mice.
An alternative role of CXCR2 in atherogenesis was unveiled
by our findings that its ligand CXCL1 mediates mobilization
of classical monocytes under hypercholesterolemia. Under
these conditions, CXCL1 may be derived from activated
endothelium covering atherosclerotic lesions (Zhou et al,
2011). The importance of CXCL1 in atherosclerotic lesion
formation and macrophage accumulation was established
by CXCL1 neutralization (Boisvert et al, 2006), which may be
explained by the influence on monocyte mobilization under
HFD identified herein. Elevated mCXCL1 levels under HFD not
only impart neutrophilia but also promote mobilization of
classical monocytes exhibiting higher CXCR2 surface expression
than their non-classical counterparts. Mobilization of classical
monocytes along with higher circulating monocyte counts
correlate with plaque sizes (Combadiere et al, 2008; Swirski
et al, 2007). In conjunction with its role in arterial cell
recruitment, the atherogenic effects of CXCR2 may thus be
attributable to HFD-mediated effects on monocyte homeostasis.
Whereas various studies in Ccr2/ mice support an
important role of CCR2 in monocyte extravasation, three
different approaches employed in this study to discern its
effects on homeostasis and recruitment, clearly imply that
arterial recruitment of classical monocytes does not require
CCR2. Accordingly, several recent studies using adoptive
transfer strategies suggest that CCR2 is dispensable for
peripheral recruitment of classical monocytes (Engel et al,
2008; Serbina & Pamer, 2006). Hence, reduced atherosclerotic
lesion sizes in Ccr2/Apoe/ mice (Boring et al, 1998) may
primarily result from lower counts of circulating classical
monoctyes rather than defects in their recruitment.EMBO Mol Med (2013) 5, 471–481
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Figure 4. CCR1 and CCR5 mediate arterial classical monocyte infiltration.
A,B. Classical monocytes (106) of indicated donor mouse strains were injected into Apoe/ recipients after labelling with the cell tracker CFSE and allowed to
circulate for 24 h. Both donor mice and recipients had been on HFD for 8 weeks. Gating strategy (A) and absolute numbers of labeled cells in the aorta
quantified by flow cytometry (B) are depicted. Denotes significant differences compared to injection of classical monocytes from Apoe/ donor mice. n¼7
for each group (Kruskal–Wallis with Dunns post hoc test).
C,D. Classical CD45.2þ monocytes (106) of indicated donor mouse strains were injected into CD45.1/Ldlr/ recipients and allowed to circulate for 24 h.
Both donor mice and recipients had been on HFD for 8 weeks. Gating strategy (C) and absolute numbers of CD45.2þ monocytes in the aorta as quantified
by flow cytometry (D) are depicted. Denotes significant differences compared to injection of classical monocytes from Apoe/ donor mice. n¼ 7 for
each group (Kruskal–Wallis with Dunns post hoc test).
E. Visualization of leucocyte adhesion to the carotid artery of Apoe/Cx3cr1epgf/þmice having been on HFD for 8 weeks. To discriminate between classical and
non-classical monocytes a PE-conjugated antibody to Gr1 was injected. Scale bar¼50mm.
F. Quantification of adhesion of classical monocytes to carotid arteries of Apoe/Cx3cr1epgf/þ mice having been on HFD for 8 weeks and having received a
single dose of indicated chemokine receptor antagonist 1 h prior to experimentation. All data are expressed as mean SD. Denotes significant differences
compared to control mice. n¼7–8 (Kruskal–Wallis with Dunns post hoc test) for each group.In contrast to CCR2 and CX3CR1, CCR1 and CCR5 were found
to be crucially involved in the recruitment of classical
monocytes to atherosclerotic arteries. Both receptors share an
overlapping spectrum of ligands among them CCL3 and CCL5,
which are present in atherosclerotic lesions through expression
or deposition. While global blockade of CCL5 receptors using
Met-CCL5 (Veillard et al, 2004) and CCR5 deficiency are
associated with reduced atherosclerotic lesion size, CCR1-
deficiency (somatic or in BM) was shown to exacerbate plaqueEMBO Mol Med (2013) 5, 471–481 formation (Braunersreuther et al, 2007). Notably, the effects of
plaque development in Ccr1/ mice appear to be highly stage-
dependent. When compared to control mice, atherosclerotic
lesions in Ccr1/Apoe/ mice are smaller after 1 month of
HFD, comparable at 2 months and larger at 3 months of HFD.
Whereas early-stage effects may be due to decreased recruit-
ment of neutrophils (Drechsler et al, 2010) or monocytes, the
exacerbation at later stages may reflect effects favoring
macrophage accumulation or a stimulation of T-cell-driven2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 477
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478immune responses (Braunersreuther et al, 2007). In contrast,
findings for CCR5 are much clearer, i.e. mice deficient in CCR5
exhibit smaller lesions with reduced numbers of mononuclear
cells in several models (Braunersreuther et al, 2007). The
non-redundant importance of both CCR1 and CCR5 identified
herein can be explained by a concept proposing a division of
labour during the emigration process, where CCR1 mediates
monocyte arrest, CCR5 supports monocyte spreading and
both contribute to transendothelial migration towards CCL5
(Weber et al, 2001).
With the emergence of two monocyte subsets, a multistep
model would envision that the relative surface expression of
adhesion molecules and chemokine receptors determines the
recruitment behaviour of each subset. Hence, higher CCR1
levels on classical monocytes may reflect its relevance for
the recruitment of this monocyte subset, whereas CCR5 is
equally expressed on both subsets, thus partially explaining an
involvement in the rare recruitment of non-classical monocytes
(Tacke et al, 2007). The prominent role of CCR1 and CCR5 can
also be related to the deposition of platelet-derived chemokines
mediating proatherogenic monocyte adhesion on endothelium
(von Hundelshausen et al, 2001). Namely, the CCR1 and
CCR5 agonist CCL5 triggers monocyte arrest, an effect further
enhanced when CCL5 interacts with CXCL4 (Koenen et al,
2009). The in vivo relevance of this synergistic interaction was
substantiated by findings that disruption of CCL5-CXCL4
heteromer formation markedly inhibited atherosclerotic
lesion formation (Koenen et al, 2009). In addition, platelet-
derived CCL5 can promote arterial recruitment of neutrophils
via engagement of CCR1 and CCR5 (Drechsler et al, 2010).
By release and deposition of granule contents, neutrophils
specifically induce adhesion and recruitment of classical
monocytes (Doring et al, 2012; Soehnlein et al, 2008; Wantha
et al, 2013). Hence, the prominent role of CCR1 and CCR5may in
part reflect the contribution of platelet- and neutrophil-borne
proteins with recruitment activity.
While previous data have suggested a function of CX3CR1 in
the recruitment of classical monocytes (Tacke et al, 2007)
despite lower expression than in non-classical monocytes,
recent data offer an alternative explanation (Landsman et al,
2009). Beyond recruitment, the CX3CL1-CX3CR1 axis confers
essential survival signals for monocytes, whereas its absence
leads to increased death of plaque monocytes and foam cells,
providing a mechanism for reduced plaque sizes of CX3CR1-
deficient mice (Landsman et al, 2009; Lesnik et al, 2003).
Accordingly, our data indicate that CX3CR1 is dispensable or
redundant in the arterial recruitment of classical monocytes but
that its role in arterial recruitment of non-classical monocytes
merits further investigation.
A group of silent or decoy receptors able to sequester
chemokines (Mantovani et al, 2006) may also be important
for monocyte trafficking in atherosclerosis. D6, an important
member of the decoy receptor family, binds a broad range of
CCR1, CCR2, and CCR5 ligands, prevents excessive infiltration
of classical monocytes and neutrophils into the myocardium
in a mouse model of myocardial infarction (Cochain et al,
2012). In addition, CXCR7 acts as a scavenger for CXCL12, 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.a chemokine important in the retention of stem cells and
neutrophils in the BM (Naumann et al, 2010; Zernecke et al,
2008). The relevance of chemokine-scavenging receptors
to atherogenic mobilization and recruitment of myeloid cell
subsets remains to be investigated. Arrest chemokines, such
as CXCL2, CXCL8, and CCL5 (alone or as heterodimer with
CXCL4) bind to the glycosaminoglycans on the surface of
endothelial cells, immobilize, and mediate firm adhesion of
rolling monocytes. The association of chemokines with heparan
sulphate can immobilize chemokines on the vessel wall to
provide strong and localized signals for integrin activation
(Ley, 2003). The interaction of chemokines with glycos-
aminoglycans or heparan sulphate-decorated CD44 may
strengthen chemokine function by various mechanisms,
including induction of conformational changes with enhanced
activity, protection from proteolytic inactivation, and induction
of dimer or heteromer formation (Rot, 2010). Notably, the
expression of D6, CXCR7, and CD44 shaping chemokine
function was unaltered by HFD in our model.
In conclusion, our data establish the quintessential impact of
classical monocytes on atheroprogression. Our findings further
identify sequential contributions of the CXCL1/CXCR2 axis in
the proatherogenic mobilization of classical monocytes and
of the CCL5 receptors CCR1 and CCR5 in the control of
their recruitment to atherosclerotic arteries. In addition, further
experimentation is needed to investigate to what extend
chemokines control post-recruitment processes contributing
to lesional macrophage accumulation.MATERIALS AND METHODS
Animals
Male Apoe/ mice and chemokine receptor-deficient male Apoe/
mice have been previously described (Braunersreuther et al, 2007;
Landsman et al, 2009; Schober et al, 2004). All strains were
backcrossed for at least 10 generations to the C57Bl/6 background.
Mice received HFD (21% fat, 0.15% cholesterol, Altromin) for
indicated time points resulting in similar lipid levels in all strains
(data not shown).
In vivo experiments
To assess the role of monocyte subsets in atheroprogression,
6 weeks-old Apoe/mice were fed a HFD for a total of 8 weeks.
After 4 weeks of HFD, stable leucopenia was induced by repeated
CPM injection (100mg/kg BW, 2/week). To reconstitute leucocytes,
age- and sex-matched Apoe/ mice receiving HFD for an equal
time period were exsanguinated. Blood was labelled with antibodies
to CD45, Gr1, and CD115, and individual monocyte subsets
were depleted by FACS sorting. Donor leucocytes were injected i.v.
2/week using one donor mouse per recipient each 1 day after CPM
application.
For adoptive transfer studies, classical monocytes were isolated from
BM by FACS sorting using antibodies to CD45, CD115, and Gr1. After
labelling the monocytes with CFSE, 106 cells were adoptively
transferred by tail vein injection to Apoe/ mice. Twenty-four hours
after transfer, aortas and hearts of recipient mice were collected forEMBO Mol Med (2013) 5, 471–481
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The paper explained
PROBLEM:
Monocytes andmacrophages are themost abundant white blood
cell subsets in atherosclerotic lesions. To enter atherosclerotic
plaques, monocytes employ specific guide cues called chemo-
kines, which induce monocyte migration via binding to
chemokine receptors. However, these ligands and receptors may
not just be important in emigration of monocytes from the blood
to the arteries, but they may also control mobilization from the
bone marrow (BM) or the life span of monocytes. Hence, the aim
of this study was to investigate the importance of various
chemokines and their receptors in atherogenic monocyte
mobilization and recruitment.
RESULTS:
With the existence of two murine monocyte subsets we first
wanted to investigate which of these two subsets is more
important in early stages of atherosclerosis. Based on a depletion
and reconstitution strategy, we could identify an important role
for classical monocytes. Under conditions of hypercholester-
olemia, a classical risk factor for atherosclerosis, classical
monocytes are produced in larger numbers in the BM and spleen
and based on data from this study we identify that the CXCL1-
CXCR2 axis is important in mobilization of classical monocytes
from these sites of production. In contrast to this and to
previously published data, CCR1 and CCR5 but not CCR2 or
CX3CR1 were found to be important chemokine receptors
mediating the accumulation of classical monocytes in athero-
sclerotic lesions.
IMPACT:
Collectively, these data establish the impact of classical
monocytes on atheroprogression, and identify a sequential role
of CXCL1 in atherogenic mobilization of classical monocytes and
CCR1/CCR5 in arterial recruitment of classical monocytes. Hence,
we here identify three potential targets for therapeutic
intervention and further studies are warranted to dissect the
specificity of such interventional strategies.further analysis. For monocyte mobilization studies, rmCXCL1/KC
(Peprotech) was injected i.v. at 40mg/kg. After 1 h, blood was drawn
and mice were sacrificed to harvest bones and spleens. Serum CXCL1
in mice was neutralized by daily administration of 5mg of anti-CXCL1
antibody (clone 124014) or IgG isotype control (clone 54447, both
R&D Systems) for 1 week and for 3 consecutive weeks every other day.
Flow cytometry
Staining of single cell suspensions of blood, BM, spleen, or aorta was
conducted using combinations of antibodies specific for CCR1-purified
(Imgenex, IMG329), CCR2-purified (Epitomics, E68), CXCR2-purified
(R&D Systems, clone 242216), CXCR7 (BioLegend, 8F11-M16), CX3CR1
(R&D Systems, AF5825), CCR5-biotinylated (BD, C34-3448), CD115-PE
(eBioscience, AFS98), CD11b-PerCp/PE-Cy7 (BD, M1/70), CD44-PerCp
(eBioscience, IM7), CD45-APC-Cy (BD, 30-F11), CD45.1-PE-Cy7
(eBioscience, A20), CD45.2-APC (eBioscience, 104), D6-purified
(ThermoScientific), F4/80-APC (eBioscience, BM8), CD62L (eBioscience,
MEL-14), Gr1-APC/PerCP (eBioscience/BD, RB6-8C5), anti-ratIgG-FITC
(eBioscience, 11-4811-85), anti-rabbit IgG-FITC (Sigma–Aldrich), SAV-
PE-Cy7 (BD). Before cell staining, red blood cell lysis was performed
using appropriate volume of lysis buffer (150mM NH4Cl; 10mM
KHCO3; 0.1mM diNaEDTA, pH 7.4). Cells were washed with HBSS
and directly analysed by flow cytometry using a FACSCantoII (BD).
Absolute cell numbers were assessed by use of CountBrightTM absolute
counting beads (Invitrogen). Data were analysed with FlowJo Software
(Tree Star Inc.). To assess expression levels of interest, geometrical
mean fluorescence intensity (MFI) after subtracting the fluorescence
minus one (FMO) control was calculated.
Histology, immunohistochemistry, and immunofluorescence
The extent of atherosclerosis was assessed in aortic root sections by
oil-red-O staining (Sigma–Aldrich), followed by computerized imageEMBO Mol Med (2013) 5, 471–481 analysis and quantification (Leica Qwin Imaging software). Collagen
content was evaluated after Sirius red staining. To define monocyte/
macrophage numbers in atherosclerotic plaque area, frozen sections
of aortic roots were washed with PBS for at least 5min followed by an
overnight incubation with a 1:400 dilution of anti Mac-2 antibody at
48C. After incubation with secondary Cy-3 conjugated antibody for
30min at room temperature, sections were analysed. To assess the
accumulation of CD45.2 donor cells within aortic root sections of CPM
treated CD45.1 mice, slides were treated with target retrieval solution
(Dako). After blocking, sections were stained for CD45.1 over 60min at
RT with an anti-CD45.1 primary (Abcam, A20) and an anti-mouse
FITC-conjugated secondary (Jackson ImmunoResearch) antibody. After
a second treatment with blocking solution containing mouse serum
and avidin sections were subsequently stained with a biotinylated
anti-CD45.2 primary (eBioscience, 104) antibody and streptavidin-
DyLight549 (Vector Laboratories). All sections were analysed using a
Leica DMLB fluorescence microscope and charge couple device (CCD)
camera. Furthermore, TUNEL staining was performed using In Situ
Cell Death Detection Kit, TMR red (Roche) to assess the number of
apoptotic/necrotic cells within aortic root sections.
Construction of the CX3CR1 Antagonist
An expression construct for the CX3CR1-antagonist F1-fractalkine
(Dorgham et al, 2009) was ordered at Genscript (Piscataway) as
E. coli codon-optimized cDNA cloned in pET26b (Merck). Recombinant
F1-fractalkine containing an N-terminal cleavable His-tag
(MHHHHHHWVDDDDK–1ILDN. . . TRNGG92) was expressed in
BL21(DE3)Star cells (Invitrogen) cultured in LB medium using a
fermenter (Lambda Instruments) for 4 h at 378C. Insoluble inclusion
bodies were washed and isolated by repeated centrifugation,
solubilized in Guanidine-HCl and refolded by rapid dilution in native
buffer essentially as described (Mizoue et al, 1999). The refolded His-2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 479
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480F1-fractalkine was enriched by sequential Ni-NTA and cation-
exchange chromatography. Finally, the leader peptide was removed
by overnight digestion with recombinant enterokinase (Merck) (1U/mg
protein) and active F1-fractalkine was separated from uncleaved His-F1-
fractalkine after cation exchange chromatography. F1-fractalkine was
dialysed in 0.1% TFA and stored lyophilized at 308C.
Intravital microscopy
Intravital microscopy of the carotid artery was performed in
Cx3cr1
egfp/þApoe/ mice as described (Drechsler et al, 2010).
J113863 to CCR1 (5mg/kg), RS504393 to CCR2 (5mg/kg), DAPTA to
CCR5 (1mg/kg), or the above-designed antagonist F1-fractalkine to
CX3CR1 (5mg/kg) were injected i.p. 1 h prior to recording. A PE-
conjugated antibody to Gr1 (5mg) was instilled via a jugular vein
catheter 15min prior to recording. Intravital microscopy was
performed using an Olympus BX51 microscope equipped with a
beam splitter to enable synchronized dual-channel recording, a
Hamamatsu 9100-02 EMCCD camera, and a 10 saline-immersion
objective. For image acquisition and analysis Olympus cellr software
was used.
Lipid detection
Serum levels of cholesterol or triglycerides were assessed by
EnzyChromTM Assay Kits (BioAssay Systems).
CXCL1 measurements in human plasma
Human plasma samples from patients with moderate hypercholester-
olemia and respective controls (Garlichs et al, 2001) were analysed for
CXCL1 by use of a commercially available ELISA kit (Quantikine, R&D
systems).
ELISA
Different ready-to-use ELISA systems were employed according to
manufacturer instructions. Murine MCP-1 and CXCL1 were deter-
mined using Quantikine ELISAs (R&D Systems). Serum levels of MCP-3
were detected by Instant ELISA (eBioscience).
PCR Array
Employing RT2 Profiler PCR Array (SABiosciences) expression of genes
encoding chemokines and their receptors could be investigated. RNA
of cells obtained from FACS was isolated using RNeasy Micro Kit
(Qiagen) and quantified by measuring the absorbance at 260nm
(A260) in a spectrophotometer. Using the RT2 First Strand Kit
(SABiosciences) cDNA has been generated and checked for quality
and efficiency of reverse transcription by RT2RNA QC PCR Array. In case
the quality of cDNA met the demands, RT2 Profiler PCR Array for
mouse chemokines and receptors was performed.
Statistics
All continuous data are expressed as mean SD. Statistical calcula-
tions were performed using GraphPad Prism 5 (GraphPad Software
Inc.). After calculating for normality by D‘Agostino Pearson omnibus
test either unpaired Student’s t-test, One-way ANOVA with Newman–
Keuls multiple comparison or nonparametric tests such as Mann–
Whitney test, or Kruskal–Wallis test with post hoc Dunn test were
used. Indicates a p-value<0.05. 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.Author contributions
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